Farrell Simon

Insider Reports History

Entity
Individual
Location
C/O Trevi Therapeutics, Inc., 195 Church Street, Floor 14, New Haven, CT
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Farrell Simon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Chief Commercial Officer Common Stock 45.7K $92.2K $2.02 Jun 20, 2023 Direct
Trevi Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 175K Feb 15, 2024 Direct

Insider Reports Filed by Farrell Simon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVI Trevi Therapeutics, Inc. Feb 15, 2024 1 $0 4 Feb 16, 2024 Chief Commercial Officer
TRVI Trevi Therapeutics, Inc. Jun 20, 2023 2 $3.19K 4 Jun 21, 2023 Chief Commercial Officer
TRVI Trevi Therapeutics, Inc. Mar 7, 2023 2 $9.58K 4 Mar 8, 2023 Chief Commercial Officer
TRVI Trevi Therapeutics, Inc. Feb 16, 2023 1 $0 4 Feb 16, 2023 Chief Commercial Officer
TRVI Trevi Therapeutics, Inc. Feb 16, 2023 0 $0 3 Feb 16, 2023 Chief Commercial Officer